Wound Management Technologies, Inc. (WNDM: OTCQB) | WNDM Medical Inc. Announces the Publication of an Unsponsored, Prospective, Randomized, Controlled, Clinical Trial That Demonstrated the Clinical Benefits of CellerateRX(R) Surgical Activated Collagen(R) Peptides
(0)
(0)